Prevalence of HIV among adults aged 15 to 49 in Togo
Togo: Prevalence of HIV among adults aged 15 to 49 was 1.6% in 2025. ▼ Falling
Prevalence of HIV among adults aged 15 to 49 in Togo, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for prevalence of hiv among adults aged 15 to 49 in Togo is 1.6%, measured in 2025. That is the lowest value across all 26 years on record.
Compared with earlier readings it is down 5.9% on the previous year and down 36.0% over ten years.
Over the whole period, prevalence of hiv among adults aged 15 to 49 in Togo peaked at 3.9% in 2000 and was at its lowest, 1.6%, in 2025.
That places Togo 19th out of 143 countries with data for 2025, putting it in the top quarter.
The long-run direction has been consistently falling across the 26 years of available data.
Prevalence of HIV among adults aged 15 to 49 in Togo, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 3.9% | — |
| 2001 | 3.9% | +0.0% |
| 2002 | 3.8% | -2.6% |
| 2003 | 3.7% | -2.6% |
| 2004 | 3.5% | -5.4% |
| 2005 | 3.4% | -2.9% |
| 2006 | 3.3% | -2.9% |
| 2007 | 3.2% | -3.0% |
| 2008 | 3.1% | -3.1% |
| 2009 | 3.0% | -3.2% |
| 2010 | 2.9% | -3.3% |
| 2011 | 2.9% | +0.0% |
| 2012 | 2.8% | -3.4% |
| 2013 | 2.7% | -3.6% |
| 2014 | 2.6% | -3.7% |
| 2015 | 2.5% | -3.8% |
| 2016 | 2.4% | -4.0% |
| 2017 | 2.3% | -4.2% |
| 2018 | 2.2% | -4.3% |
| 2019 | 2.1% | -4.5% |
| 2020 | 2.1% | +0.0% |
| 2021 | 2.0% | -4.8% |
| 2022 | 1.9% | -5.0% |
| 2023 | 1.8% | -5.3% |
| 2024 | 1.7% | -5.6% |
| 2025 | 1.6% | -5.9% |
Togo compared with similar countries
- Togo's 1.6% is above the median for lower middle income countries, which is 0.6%, 2.9× the median. (40 countries reporting)
- Togo's 1.6% is above the median for Sub-Saharan Africa, which is 1.4%, 1.1× the median. (45 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.5% | 3.0% | 3.9% | 10 |
| 2010s | 2.5% | 2.1% | 2.9% | 10 |
| 2020s | 1.8% | 1.6% | 2.1% | 6 |
Countries ranked near Togo
More health data for Togo
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7948 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 875 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,021 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 2.86 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0681 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is prevalence of hiv among adults aged 15 to 49 in Togo?
- Prevalence of hiv among adults aged 15 to 49 in Togo was 1.6% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of hiv among adults aged 15 to 49 recorded in Togo?
- The highest recorded value was 3.9% in 2000.
- What is the lowest prevalence of hiv among adults aged 15 to 49 recorded in Togo?
- The lowest recorded value was 1.6% in 2025.
- How does Togo rank for prevalence of hiv among adults aged 15 to 49?
- Togo ranks 19th out of 143 countries with data for 2025.
- Is prevalence of hiv among adults aged 15 to 49 rising or falling in Togo?
- Over the last ten years it is down 36.0%. The long-run trend across the full record is falling.
- Where does this Togo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of HIV among adults aged 15 to 49 (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).